Background and objective Pneumothorax is a co‐morbidity in patients with idiopathic
pulmonary fibrosis (IPF). However, its incidence, risk factors and prognostic significance in …

BACKGROUND: The lung function of patients with idiopathic pulmonary fibrosis (IPF) has
not been characterized in detail. OBJECTIVE: To characterize the heterogeneous …

Aims Patients with idiopathic pulmonary fibrosis (IPF) receiving antifibrotic medication and
patients with non-IPF fibrosing lung disease often demonstrate rates of annualised forced …

When Deep Blue first defeated Kasparov: is a machine stronger than a radiologist at predicting
prognosis in idiopathic pulmonary fibrosis? | European Respiratory Society Skip to main content …

Objective To investigate the prognostic implications of clinical, radiographic, and
physiological variables in idiopathic pulmonary fibrosis (IPF). Methods The clinical …

Background The results of a quantitative analysis of computed tomography (CT) of interstitial
lung disease (ILD) using a computer-aided detection (CAD) technique were correlated with …

Background: Medical Research Council (MRC) chronic dyspnea scale, used for the
estimation of disability due to dyspnea, may serve as a simple index of disease severity and …

Background and objective Combined pulmonary fibrosis and emphysema (CPFE) is
characterized by preserved lung volume and slower lung function decline. However, it is …

In the past few years, there has been a notable rise in the incidence and prevalence of
idiopathic pulmonary fibrosis (IPF) on a global scale. A considerable body of research has …

Background: Two antifibrotic medications, pirfenidone and nintedanib, have been approved
as treatments for idiopathic pulmonary fibrosis (IPF)—a life-threatening interstitial lung …